Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

This study is testing a new cell therapy called CELZ-201 — made from special pancreatic stem cells — to see if it can help preserve the body's own insulin production in people who were recently diagnosed with type 1 diabetes. In type 1 diabetes, the immune system destroys the insulin-making beta cells in the pancreas. This therapy aims to protect and restore some of that function. **You may be eligible if...** - You are between 18 and 35 years old - You were diagnosed with type 1 diabetes within the past year - Your body is still producing some insulin (confirmed by a blood test called C-peptide) - You have at least two positive antibody markers for type 1 diabetes - Your blood sugar control and kidney function meet the required levels **You may NOT be eligible if...** - Your BMI is above 28, or your HbA1c is above 9% - You have a history of heart disease, liver disease, severe pancreatic problems, or a bleeding disorder - You have uncontrolled thyroid disease - You have poorly controlled high blood pressure - You are pregnant or planning to become pregnant Talk to your doctor to see if this trial is right for you.